Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas

Neuro-Oncology

Volumn 8, Issue 1, 2006, Pages 38-46

  Shah, Gaurav D ^b   Kesari, Santosh ^a,b,c   Xu, Ronghui ^a   Batchelor, Tracy T ^c   O'Neill, Alison M ^c   Hochberg, Fred H ^c   Levy, Brenda ^a   Bradshaw, Joanna ^a   Wen, Patrick Y ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Magnetic resonance imaging; Malignant glioma; RECIST; Tumor response

Indexed keywords

ANTINEOPLASTIC AGENT; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; BRAIN TUMOR; CANCER GRADING; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; FOLLOW UP; GLIOMA; HUMAN; IMAGING SYSTEM; INTERMETHOD COMPARISON; LINEAR SYSTEM; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; RISK ASSESSMENT; SOLID TUMOR; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; THREE DIMENSIONAL IMAGING; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR VOLUME; VOLUMETRY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; DIAGNOSTIC IMAGING; DISEASE-FREE SURVIVAL; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 31544437142     PISSN: 15228517     EISSN: None     Source Type: Journal    
DOI: 10.1215/S1522851705000529     Document Type: Article

References (29)

1. Anderson, J.R., Cain, K.C., and Gelber, R.D. (1983) Analysis of survival by tumor response. J. Clin. Oncol. 1, 710-719.
2. Aoyama, H., Shirato, H., Nishioka, T., Hashimoto, S., Tsuchiya, K., Kagei, K., Onimaru, R., Watanabe, Y., and Miyasaka, K. (2001) Magnetic resonance imaging system for three-dimensional conformal radiotherapy and its impact on gross tumor volume delineation of central nervous system tumors. Int. J. Radiat. Oncol. Biol. Phys. 50, 821-827.
3. Batchelor, T.T., Gilbert, M.R., Supko, J.G., Carson, K.A., Nabors, L.B., Grossman, S.A., Lesser, G.J., Mikkelsen, T., and Phuphanich, S. (2004) Phase 2 study of weekly irinotecan in adults with recurrent malignant glioma: Final report of NABTT 97-11. Neuro-Oncology 6, 21-27.
4. Chisholm, R.A., Stenning, S., and Hawkins, T.D. (1989) The accuracy of volumetric measurement of high-grade gliomas. Clin. Radiol. 40, 17-21.
5. Erasmus, J.J., Gladish, G.W., Broemeling, L., Sabloff, B.S., Truong, M.T., Herbst, R.S., and Munden, R.F. (2003) Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: Implications for assessment of tumor response. J. Clin. Oncol. 21, 2574-2582.
6. Fountas, K.N., and Karampelas, I. (2004) Proton magnetic resonance spectroscopic imaging can predict length of survival in patients with supratentorial gliomas. Neurosurgery 55, 257-258.
7. Galanis, E., Maurer, M.J., Ballman, K.V., O'Fallon, J., Sykora, R., Castillo, R., Buckner, J.C., and Erickson, B.J., for the North Central Cancer Treatment Group (2003) Validation of neuroradiologic response assessment in gliomas: RECIST (1D) vs 2D measurements vs computer-assisted tumor area vs volume. Proc. Am. Soc. Clin. Oncol. 22, 106. Available at www.asco.org (abstract 423).
8. Gehan, E.A., and Tefft, M.C. (2000) Will there be resistance to the RECIST (Response Evaluation Criteria in Solid Tumors)? J. Natl. Cancer Inst. 92, 179-181 (editorial).
9. Guerin, C., Olivi, A., Weingart, J.D., Lawson, H.C., and Brem, H. (2004) Recent advances in brain tumor therapy: Local intracerebral drug delivery by polymers. Invest. New Drugs 22, 27-37.
10. James, K., Eisenhauer, E., Christian, M., Terenziani, M., Vena, D., Muldal, A., and Therasse, P. (1999) Measuring response in solid tumors: Uni-dimensional versus bidimensional measurement. J. Natl. Cancer Inst. 91, 523-528.
11. Joe, B.N., Fukui, M.B., Meltzer, C.C., Huang, Q.S., Day, R.S., Greer, P.J., and Bozik, M.E. (1999) Brain tumor volume measurement: Comparison of manual and semiautomated methods. Radiology 212, 811-816.
12. Kleinberg, L.R., Weingart, J., Burger, P., Carson, K., Grossman, S.A., Li, K., Olivi, A., Wharam, M.D., and Brem, H. (2004) Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: Implications for patient management. Cancer Invest. 22, 1-9.
13. Lavin, P.T., and Flowerdew, G. (1980) Studies in variation associated with the measurement of solid tumors. Cancer 46, 1286-1290.
14. Macdonald, D.R., Cascino, T.L., Schold, S.C., Jr., and Cairncross, J.G. (1990) Response criteria for phase II studies of supratentorial malignant glioma. J. Clin. Oncol. 8, 1277-1280.
15. Mazzara, G.P., Velthuizen, R.P., Pearlman, J.L., Greenberg, H.M., and Wagner, H. (2004) Brain tumor target volume determination for radiation treatment planning through automated MRI segmentation. Int. J. Radiat. Oncol. Biol. Phys. 59, 300-312.
16. Miller, A.B., Hoogstraten, B., Staquet, M., and Winkler, A. (1981) Reporting results of cancer treatment. Cancer 47, 207-214.
17. Moonis, G., Liu, J., Udupa, J.K., and Hackney, D.B. (2002) Estimation of tumor volume with fuzzy-connectedness segmentation of MR images. AJNR Am. J. Neuroradiol. 23, 356-363.
18. Ostergaard, L., Hochberg, F.H., Rabinov, J.D., Sorensen, A.G., Lev, M., Kim, L., Weisskoff, R.M., Gonzalez, R.G., Gyldensted, C., and Rosen, B.R. (1999) Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors. J. Neurosurg. 90, 300-305.
19. Park, J.O., Lee, S.I., Song, S.Y., Kim, K., Kim, W.S., Jung, C.W., Park, Y.S., Im, Y.H., Kang, W.K., Lee, M.H., Lee, K.S., and Park, K. (2003) Measuring response in solid tumors: Comparison of RECIST and WHO response criteria. Jpn. J. Clin. Oncol. 33, 533-537.
20. Prados, M.D., Yung, W.K., Fine, H.A., Greenberg, H.S., Junck, L., Chang, S.M., Nicholas, M.K., Robins, H.I., Mehta, M.P., Fink, K.L., Jaeckle, K.A., Kuhn, J., Hess, K.R., and Schold, S.C., Jr. (2004) Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study. Neuro-Oncology 6, 33-37.
21. Shi, W.M., Wildrick, D.M., and Sawaya, R. (1998) Volumetric measurement of brain tumors from MR imaging. J. Neurooncol. 37, 87-93.
22. Shinoda, J., Yano, H., Ando, H., Ohe, N., Sakai, N., Saio, M., and Shimokawa, K. (2002) Radiological response and histological changes in malignant astrocytic tumors after stereotactic radiosurgery. Brain Tumor Pathol. 19, 83-92.
23. Sorensen, A.G., Patel, S., Harmath, C., Bridges, S., Synnott, J., Sievers, A., Yoon, Y.H., Lee, E.J., Yang, M.C., Lewis, R.F., Harris, G.J., Lev, M., Schaefer, P.W., Buchbinder, B.R., Barest, G., Yamada, K., Ponzo, J., Kwon, H.Y., Gemmete, J., Farkas, J., Tievsky, A.L., Ziegler, R.B., Salhus, M.R., and Weisskoff, R. (2001) Comparison of diameter and perimeter methods for tumor volume calculation. J. Clin. Oncol. 19, 551-557.
24. St. Clair, W.H., and Given, C.A. (2003) Stereotactic radiosurgery associated neurotoxicity. Technol. Cancer Res. Treat. 2, 147-152.
25. Therasse, P., Arbuck, S.G., Eisenhauer, E.A., Wanders, J., Kaplan, R.S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A.T., Christian, M.C., and Gwyther, S.G. (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J. Natl. Cancer Inst. 92, 205-216.
26. Vos, M.J., Uitdehaag, B.M., Barkhof, F., Heimans, J.J., Baayen, H.C., Boogerd, W., Castelijns, J.A., Elkhuizen, P.H., and Postma, T.J. (2003) Interobserver variability in the radiological assessment of response to chemotherapy in glioma. Neurology 60, 826-830.
27. Warren, K.E., Patronas, N., Aikin, A.A., Albert, P.S., and Balis, F.M. (2001) Comparison of one- two-, and three-dimensional measurements of childhood brain tumors. J. Natl. Cancer Inst. 93, 1401-1405.
28. Weltens, C., Menten, J., Feron, M., Bellon, E., Demaerel, P., Maes, F., Van den Bogaert, W., and van der Schueren, E. (2001) Interobserver variations in gross tumor volume delineation of brain tumors on computed tomography and impact of magnetic resonance imaging. Radiother. Oncol. 60, 49-59.
29. WHO (1979) Handbook for Reporting Results of Cancer Treatment. Offset Publication No. 48. Geneva: World Health Organization.